ESPR
Esperion Therapeutics IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$811.73M
P/E Ratio
0.00
EPS
$0.00
Beta
1.07
52W High
$4.17
52W Low
$0.95
50-Day MA
$2.72
200-Day MA
$3.00
Dividend Yield
—
Profit Margin
-1.78%
Forward P/E
4.64
PEG Ratio
-4.78
About Esperion Therapeutics Inc
Esperion Therapeutics, Inc., a pharmaceutical company, develops and markets drugs for the treatment of patients with high low-density lipoprotein cholesterol in the United States and internationally. The company is headquartered in Ann Arbor, Michigan.
Fundamentals
| Revenue (TTM) | $418.24M |
| Gross Profit (TTM) | $241.70M |
| EBITDA | $75.89M |
| Operating Margin | -8.22% |
| Return on Equity | -260.80% |
| Return on Assets | 12.00% |
| Revenue/Share (TTM) | $1.89 |
| Book Value | $-1.23 |
| Price-to-Book | 98.42 |
| Price-to-Sales (TTM) | 1.94 |
| EV/Revenue | 2.171 |
| EV/EBITDA | 11.42 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 23.20% |
| Shares Outstanding | $257.69M |
| Float | $234.27M |
| % Insiders | 0.91% |
| % Institutions | 78.08% |
Historical Volatility
HV 10-Day
42.25%
HV 20-Day
64.19%
HV 30-Day
63.52%
HV 60-Day
72.16%
HV Rank
17.1%
Volatility is currently contracting
Analyst Ratings
Consensus ($3.19 target)
3
Strong Buy3
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026